Clinical Trial Update: Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 study from MD Anderson evaluating perioperative chemotherapy plus immunotherapy followed by surgery for localized esophageal adenocarcinoma and gastro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING